Edit concept Question Editor Create issue ticket


The state of low gastric acid production in the stomach is defined as hypochlorhydria, whereas an absence thereof is termed as achlorhydria. Achlorhydria is directly connected to multiple conditions and is primarily a result of chronic vomiting, stomach neoplasm, niacin deficiency, hypothyroidism or helicobacter pylori infection.


In order to assess a patient suspected of suffering from achlorhydria, a detailed medical history should be obtained. A physician should evaluate the corresponding risk factors: Gastric bypass surgery, chronic PPI use, persisting H. pylori infection and autoimmune diseases (eg, diabetes, autoimmune thyroid disease).

In order to determine the existence of possible complications arising from achlorhydria (bacterial overgrowth, intestinal metaplasia, hip fracture) additional questions are of vital importance. A doctor will investigate the presence of weight loss, feeling of fullness too early in the course of a meal, bowel movement frequency, abdominal discomfort and bloating, as well as potential reflux symptoms. Patients should also undergo tests to determine a possible anemia, since an acidic pH mediates the absorption of iron and achlorhydric patients often develop iron deficiency and subsequent anemia [11].

A lack of various nutrients resulting from a possible bacterial overgrowth can also lead to neurological symptoms. For this reason, a corresponding medical history, including the existence of visual changes, hallucinations, paresthesias, ataxianumbness, gait imbalance, memory impairment, personality and mood alterations, should not be omitted.

  • […] esp. lower limbs with myalgia paraesthesia ataxia and gait disorders ;also psychological disorders like weak memory, mood disorders personality disorders, hallucinations etc. these patients are prone to infection of Vibrio Vulnificus and other usually[atomictherapy.org]
  • One complication that can arise because of these deficiencies is weak bones, which can result in fractures, especially of the hip.[verywell.com]
  • List of side effects Abdominal or stomach pain chills clay-colored stools cough dark urine diarrhea difficulty with swallowing dizziness fast heartbeat fever general feeling of tiredness or weakness headache hives itching large, hive-like swelling on[rawpaleodietforum.com]
  • Abstract In this study, two dissolution models were developed to achieve in vitro-in vivo relationship for immediate release formulations of Compound-A, a poorly soluble weak base with pH-dependent solubility and low bioavailability in hypochlorhydric[ncbi.nlm.nih.gov]
  • Bacterial overgrowth and B12 deficiency (pernicious anemia) can cause micronutrient deficiencies that result in various clinical neurological manifestations, including visual changes, paresthesias, ataxia, limb weakness, gait disturbance, memory defects[en.wikipedia.org]
  • Symptoms Symptoms of pernicious anemia include fatigue, weakness, waxy pallor, shortness of breath, rapid heartbeat, unsteady gait, smooth tongue, gastrointestinal disturbances, and neurological problems.[britannica.com]
  • The classical components of the syndrome include: - SIDEROPENIA & HYPOCROMIC MICROCYTIC ANEMIA Symptoms resulting from anemia (weakness, pallor, fatigue, tachycardia) may dominate the clinical picture. - DYSPHAGIA & ODINOPHAGIA The dysphagia is usually[flipper.diff.org]
  • It is also a known fact that gastric atrophy is directly linked to intestinal metaplasia and increases the risk of patients for developing a gastric adenocarcinoma, by 2 or 3 times. 16% of patients suffering from dyspepsia have been diagnosed with gastric[symptoma.com]
  • The most common cause for achlorhydria is treatment of gastroduodenal ulcers, nonulcer dyspepsia, or gastroesophageal reflux with proton pump inhibitors (substituted benzimidazoles, eg, omeprazole).[mayomedicallaboratories.com]
  • Pylori infection in patients with functional dyspepsia: A cross-section study. BMC Research Notes. 2012;5:206. 5. King CE, Leibach J, Toskes PP. Clinically significant vitamin B12 deficiency secondary to malabsorption of protein-bound vitamin B12.[drjockers.com]
Chronic Abdominal Pain
  • Two patients with chronic abdominal pain and fasting hypergastrinemia had increases in serum gastrin of 440 and 300 pg/ml after injection of 2 U/kg Secretin-KABI. Both subsequently proved to have pentagastrin-fast achlorhydria.[ncbi.nlm.nih.gov]
Recurrent Diarrhea
  • Small intestinal bacterial overgrowth can result in recurrent diarrhea with malabsorption, D-lactic acidosis, and an increased risk of endogenous infection.[emedicine.medscape.com]
Limb Weakness
  • Bacterial overgrowth and B12 deficiency (pernicious anemia) can cause micronutrient deficiencies that result in various clinical neurological manifestations, including visual changes, paresthesias, ataxia, limb weakness, gait disturbance, memory defects[en.wikipedia.org]


The first step towards the diagnosis of a suspected achlorhydria is the evaluation of gastric pH. Gastric fluid is collected via naso- or orogastric tubes following the patient's fasting. pH values >3.5 constitute a definite sign of achlorhydria [12]. Further tests may be used to determine the concentration of gastrin in blood, which is usually high in achlorhydric patients. Levels of pepsinogen A (PgA) in the blood are also used to determine the existence of achlorhydria, with levels <17 mcg/L being a strong indication of the condition. Pepsinogen is also an enzyme mediating the digestion of food [13].

Another useful test towards the diagnosis of achlorhydria involves the evaluation of gastric bacterial overgrowth, since it is a state that is many times responsible for hypo- or achlorhydria. This can be performed with a gastric or upper intestinal aspirate culture, with a breath test that assesses the release of hydrogen after a patients ingests plain sugar or a breath test involving the ingestion of specific, radioactive sugar. In the latter method, radioactive sugar is actually digested by gastric bacteria; should an overgrown population exist intragastrically, the patient is expected to exhale large amounts of radioactivity, a product of bacterial digestion.

  • CONCLUSIONS: We have identified a 14.8% false-positive rate in SST in patients with hypochlorhydria or achlorhydria.[ncbi.nlm.nih.gov]
  • The other subgroup (IB) had little atrophy and only mild hypochlorhydria; the gastric findings were indistinguishable from those in many subjects with normal absorption.[ncbi.nlm.nih.gov]
  • Hypochlorhydria Defined - Hypochlorhydria is the condition in which only low amounts of stomach acid is produced.[crohnsforum.com]
  • At least seven of them had hypochlorhydria. Of 540 persons with a normal serum gastrin one had achlorhydria. Determination of the serum gastrin appeared to be fairly reliable as a method of detecting achlorhydria.[ncbi.nlm.nih.gov]
  • We conclude that achlorhydria may be associated after injection of Secretin-KABI with a false-positive rise in fasting serum gastrin concentration of greater than 200 pg/ml and that gastric analysis for hypochlorhydria should be performed before secretin[ncbi.nlm.nih.gov]
Microcytic Anemia
  • It has been reported a frequent finding in microcytic anemia, 1 , 2 hyperthyroidism 3 and chronic arthritis. 4 For many years dilute hydrochloric acid has been employed in various dermatologic disorders, particularly acne rosacea, and more recently it[nejm.org]
  • The classical components of the syndrome include: - SIDEROPENIA & HYPOCROMIC MICROCYTIC ANEMIA Symptoms resulting from anemia (weakness, pallor, fatigue, tachycardia) may dominate the clinical picture. - DYSPHAGIA & ODINOPHAGIA The dysphagia is usually[flipper.diff.org]


Intervention in cases of achlorhydric patients is individualized depending on the cause of the condition:

  • H. pylori infection: Possible need for antibiotics and PPIs [14]. The treatment regime is continued for 14 days or more to achieve a radical elimination of bacteria. Additional courses may be necessary, should the re-assessment reveal a persisting H. pylori infection.
  • Tumors: Combination of surgical excision and chemotherapy and/or radiation therapy. Unfortunately these processes are also a cause of achlorhydria.
  • Autoimmune causes: Low doses of corticosteroids. Corticosteroids may be particularly effective in achlorhydria accompanied by eosinophilic gastroenteritis.
  • Vitamin deficiencies and pernicious anemia: Nutritional supplements (esp. vitamin B12 [15]), and thiamine.


Potential outcomes and complications of the disease have not yet been fully investigated. Nevertheless, achlorhydria is considered to be a precancerous stage, as the risk of malignancy is high.

An interesting fact is that a gastric environment of normal pH value only renders it possible for bacteria of the helicobacter species to grow, a stomach with a pH >4 also allows for the development of other, non-helicobacter species. There have been experiments proving that non-helicobacter bacteria can also cause atrophic gastritis and subsequent gastric carcinoma [4]. 


Hydrochloric acid is produced by the gastric lining, specifically from the parietal cells and has two functions which are vital for the digestion of food. It converts pepsinogen into pepsin and together with other chemical elements (enzymes), it is responsible for digestion. The absence or very low concentration of hydrochloric acid leads to problems with normal digestion, since its function cannot be carried out by the other enzymes alone, even pepsin needs an acidic intragastric pH in order to function.

There are many conditions leading to achlorhydria:

  • Gastric neoplasms: A cancerous tumor of or adjacent to the regions where HCl is produced is one of the primary causes of achlorhydria. A pancreatic neoplasm (VIPoma) may also cause achlorhydria. 
  • H. pylori infection reduces acid production and neutralizes the already existing HCl [2].
  • Autoimmune diseases: Antibodies against the parietal cells cause a reduction of gastric acid secretion.
  • Surgical processes such as gastric bypass or resection [4].
  • Proton-pump inhibitor abuse (PPI), usually to treat gastroesophageal reflux disease [3].
  • Radiation therapy of the stomach.

Even though the condition is defined as achlorhydria, in reality it is very unusual and rare for a total absence of gastric acid to be the case. Generally, gastric acid concentration is severely diminished, so that its quantity does not suffice to carry out digestion.


The exact incidence and prevalence of achlorhydria are unknown. Gastric atrophy, however, which corresponds to a concentration of pepsinogen I less than 25 nanograms/mL or pepsinogen I/II ratio less than 3.0, has been calculated by studies to be present in 10-15% of the senior population [5]. It is also a known fact that gastric atrophy is directly linked to intestinal metaplasia and increases the risk of patients for developing a gastric adenocarcinoma, by 2 or 3 times. 16% of patients suffering from dyspepsia have been diagnosed with gastric atrophy, whose incidence fluctuates between 0%-11% per year. An important observation is that patients with an H. pylori infection tend to exhibit gastric atrophy more frequently than those unaffected by the infection [7].

Another autoimmune disease, pernicious anemia, caused by autoimmunity against the parietal cells and/or the intrinsic factor, has been found to be present in just over 2% of the population aged over 60 years old. In a study conducted among the German population, researchers evaluated 9684 patients aged 50-74 years old and used the ELISA technique to detect parietal cell autoantibodies. Antibodies against the hydrogen-potassium-stimulated adenosine triphosphatase (H+/K+ ATPase), the proton pump of the parietal cell, were found in 20% of the participants [6]. Pernicious anemia causes cobalamin deficiency.

Sex distribution
Age distribution


As mentioned above, the existence of an H. pylori infection plays a crucial role in the secretion of gastric acid. Even though 50% of the world's population are H. pylori carriers, not everyone exhibits an active infection. In those patients who do exhibit it, the production of gastric acid is considerably diminished and usually, the gastritis caused affects the whole of the stomach (pangastritis). An H. pylori infection produces this effect on the stomach via two mechanisms, the microorganism itself produces toxins that hinder the secretion of HCl from parietal cells and the inflammatory process that accompanies an H. pylori infection further inhibits gastric acid production [1]. For instance, toxins released by H. pylori inhibit the expression of human hydrogen-potassium-stimulated adenosine triphosphatase (H+/K+ ATPase) alpha-subunit and hinder the transport of H+/K+ ATPase-containing tubulovesicles to the apical membrane, both indicate direct damage. On the other hand, interleukin-1beta, tumour necrosis factor-alpha as well as other cytokines, all by-products of the inflammatory process, also damage parietal cells, resulting in a diminished production of gastric acid [1]. A complication of this process is the loss of parietal cells and the oxyntic glands atrophy and from that point and on, achlorhydria is irreversible. A potential explanation for the damage caused to the stomach by a H. pylori infection suggests that this is mediated by autoantibodies against the Lewis x and y blood group antigens, which are expressed both by the microorganism's lipopolysaccharide and the proton pump. These antibodies are believed to result in autoimmune gastritis and the subsequent gastric atrophy [1] [8].

Autoimmune gastritis is also observed in patients affected by other autoimmune diseases, such as autoimmune thyroiditis, vitiligo, Graves diseasediabetes mellitus, idiopathic adrenocortical insufficiency, postpartum thyroiditis, primary biliary cirrhosis and hypoparathyroidism [9] [10]. Autoantibodies against the parietal cell and intrinsic factor are exhibited in 32% and 12% respectively, of patients affected by primary biliary cirrhosis [9].

Surgical interventions such as antrectomy with vagotomy also play an important role in the development of achlorhydria. The process of antrectomy removes gastrin, which stimulates the production of acid and is secreted by antral G cells. It also removes the hormone which controls oxyntic mucosa growth. Vagotomy on the other hand prevents stimulants such as the sight, taste and smell of food from being transmitted to the brain and ultimately perceived. A further reflux of bile into the stomach, a complication of the surgical procedure, deteriorates the problem, contributing to the atrophy and inflammation.

With reference to gastrin, it is the hormone primarily stimulating the production of gastric acid upon the ingestion of food. Antral G cells produce gastrin, which then performs a dual function, it acts directly on the acid-secreting parietal cells and indirectly stimulates histamine production from enterochromaffin-like (ECL) cells. Histamine is released to the region of the nearby parietal cells, binding to histamine H2 receptors and further stimulating the production of gastric acid. After digestion has been completed, somatostatin (SST) gives the signal for the cessation of gastrin production. SST is produced by the antral D cells in response to luminal acid. In cases of achlorhydria, luminal acid does not cause the proper effect on SST, whose production is diminished. As a result, it fails to control the secretion of gastrin (disinhibition) and to perform its task, leading to hypergastrinemia. This mechanism also helps to comprehend the pathway leading from hypergastrinaemia to malignancy. Given that gastrin also induces the growth of the oxyntic mucosa, a failure to restrain its production leads to a continually growing mucosa. If no intervention to correct gastrin levels is performed, ECL cells become hypertrophic. If the phenomenon continues, ECL cells proceed from hyperplasia to dysplasia and, ultimately, to potential cancerous tumors.


There are no specific guidelines as to how an individual can prevent the occurrence of achlorhydria. Following basic hygienic measures does, however, prevent an H. pylori infection in many cases, and following a therapeutic scheme upon such a diagnosis, helps to eradicate the bacterium from the intragastric region. In this way, the danger of atrophic or autoimmune gastritis is diminished. Since achlorhydria is also caused by gastric surgery, its incidence can also be reduced by surgeons avoiding a great number of surgical processes on the stomach, in cases where conservative treatment can be applied.


The simple definition of achlorhydria involves the complete absence of HCl in gastric secretions [1]. Pathophysiologically, it has also been defined in the following ways:

  1. As the existence of a maximum acid output in response to an effective stimulus, leading to an intragastric pH> 5.09 (men) and >6.81 (women).
  2. As the state which presents with a ratio of serum pepsinogen I/pepsinogen II <2.9.
  3. As the existence of a maximum acid output <6.9 m/mole/h (men) and <5.0 m/mole/h (women).

Pathologic and surgical causes of achlorhydria are all described below. In general, this condition is considered a precancerous stage, since it is linked to metaplasia of the gastric mucosa, which can then further result in a dysplastic condition.

Patient Information

Achlorhydria is a clinical condition featuring diminished or absent production of acidic fluid in the stomach. It is linked with multiple medical conditions.


Achlorhydria is caused by many types of conditions, some of which include:

  • Hypothyroidism which is responsible for the the slowdown of metabolism
  • Autoimmune diseases which produce antibodies against the stomach cells that produce acid
  • Drugs or antacids which lower the secretion of acid or its transportation
  • Atrophic gastritis, pernicious anemia or stomach cancer
  • Helicobacter pylori infection, where the bacteria damage acid producing cells in order to maintain a less acidic pH to aid their survival
  • Stomach radiation therapy
  • Gastric surgical procedures (Roux-en-Y, duodenal stitch etc). These procedures lead to the incapacitation of gastric regions that produce acids. 
  • Niacin deficiency (pellagra)
  • Pancreatic tumors (somatostatinomas, VIPomas) or vasoactive intestinal peptides
  • Other rare disorders like mucolipidosis (IV type)


The clinical manifestation of achlorhydria includes:

Achlorhydria causes symptoms that closely resemble those of gastroesophagel reflux disease, even though the mechanisms involved in the two conditions are completely distinct. A crucial complication of achlorhydria involves the potential overgrowth of bacteria in the stomach, such as the vibrio vulnificus, which is found in seafood. Prolific amounts of bacteria in the stomach may lead to diarrhoic phenomena or vitamin/nutient deficiency, including zinc, magnesium, B,C and K complex vitamins; these conditions may further lead to multiple pathologies, ranging from neuromuscular disorders to fatal diseases. In cases of achlorhydria, food is not digested successfully by the responsible enzymes, a state which causes pain, bloating and a great amount of discomfort after consuming food.


Achlorhydria is diagnosed after the evaluation of stomach pH value, levels that are greater than 4.0 even after stimulation with pentagastrin are typical of achlorhydria. Gastrin levels in the blood are also a common finding. Lastly, almost 90% of patients with achlorhydria are found to have antibodies against the  H+/K+ ATP-ase proton pump.


The most successful way of treating achlorhydria is by eradicating its initial cause, as described before. Apart from the different types of intervention depending on its causes, many doctors also prescribe Betaine HCL/Betaine hydrochloride, in order to increase the gastric acids and facilitate proper digestion. Betaine HCL contains chloride, which releases hydrochloric acid in the stomach, partially compensating for the reduced amount of acidic fluids that the stomach itself can naturally produce. It is sold as a preparation containing pepsin, an enzyme partaking in the digestion process.



  1. Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842-1860.
  2. Argent RH, Thomas RJ, Aviles-Jimenez F, et al. Toxigenic Helicobacter pylori infection precedes gastric hypochlorhydria in cancer relatives, and H pylori virulence evolves in these families. Clin Cancer Res. 2008;14:2227-2235.
  3. Shi S, Klotz U. Proton-pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008;64:935-951.
  4. Hou W, Schubert ML. Treatment of gastric carcinoids. Curr Treat Options Gastroenterol. 2007;10:123-133.
  5. Weck MN, Stegmaier C, Rothenbacher D, et al. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther. 2007;26:879-887.
  6. Zhang Y, Weck MN, Schöttker B, et al. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013; 22:821-826.
  7. Kuipers EJ, Pérez-Pérez GI, Meuwissen SG, et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995; 87:1777-1780.
  8. D'Elios MM, Bergman MP, Azzurri A, et al. H+,K+-ATPase (proton-pump) is the target autoantigen of TH1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology. 2001; 120:377-386.
  9. Liaskos C, Norman GL, Moulas A, et al. Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis. Clin Chim Acta. 2010; 411:411-415.
  10. Kasperlik-Zaluska AA, Czarnocka B, Czech W, et al. Secondary adrenal insufficiency associated with autoimmune disorders: a report of twenty-five cases. Clin Endocrinol (Oxf). 1998; 49:779-783.
  11. Sharma VR, Brannon MA, Carloss EA. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J. 2004; 97:887-889.
  12. Moore EW, Scarlata RW. The determination of gastric acidity by the glass electrode. Gastroenterology. 1965; 49:178-188.
  13. Richter C, Tanaka T, Yada RY. Mechanism of activation of the gastric aspartic proteinases: pepsinogen, progastricsin and prochymosin. Biochem J. 1998; 355:481-490.
  14. Malfertheiner P. Helicobacter pylori infection - management from a European perspective. Dig Dis. 2014; 32:275-280.
  15. Den Elzen WP, Groeneveld Y, De Ruijter W, et al. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals. Aliment Pharmacol Ther. 2008; 27:491-497.

Ask Question

5000 Characters left Format the text using: # Heading, **bold**, _italic_. HTML code is not allowed.
By publishing this question you agree to the TOS and Privacy policy.
• Use a precise title for your question.
• Ask a specific question and provide age, sex, symptoms, type and duration of treatment.
• Respect your own and other people's privacy, never post full names or contact information.
• Inappropriate questions will be deleted.
• In urgent cases contact a physician, visit a hospital or call an emergency service!
Last updated: 2017-08-09 17:30